Research indicates that migraine can be prevented with cannabinoid
When it comes to preventing migraine, cannabinoids is as effective as any other available drug. Cannabinoids is very effective with patients that have lived with migraine for a very long period.
From recent research presented in Amsterdam, at the the 3rdCongress of the European Academy of Neurology, Netherlands – these are what was found.
Migraine is the most dominant illness in the world – as stated by the Migraine Research Foundation, and about 1 billion individuals are affected. Over 38 million adults and children in the U.S. experience migraine.
Most people just consider it to be bad headache; however, migraine could turn out to be very serious. Usually, migraine attacks brings this intense, persistent throbbing pain on either one or the both sides of the head, and it can last from about 4 – 72 hours.
Other incapacitating symptoms may follow these migraine attacks – symptoms like nausea, light sensitivity, dizziness, face numbness, vomiting or extremities.
Cluster headaches are short and painful headaches that can be experienced multiple times in one day. The pain is usually on one side of the brain – around the eye. This headache isn’t as popular as migraine, affecting less than 1 in a thousand adults around the world.
55% Reduction in Acute Pain
Researched carried out has shown that cannabinoids (the chemical compounds of marijuana) can assist in the treatment of headache disorders.
Research leader of the Interuniversity Center in Italy – Dr. Maria Nicolodiand and his team decided to further study this association by examining the effectiveness of cannabinoids in cluster headache and migraine treatment.
In the first stage of the research, 48 adults with severe migraine were analysed. Different doses of the combination of two compounds were offered to the participants. One compound contained 19% tetrahydrocannabinol (THC), which is marijuana’s basic psychoactive constituent, while 9% canabidiol (another active compound from marijuana) was contained in the other compound.
The study shows that 55% of the acute migraine reduced when offered the THC-CBD combination at 200 milligrams or higher. Also, the team reported that THC-CBD doses below 100 milligrams didn’t have any effect on acute pain.
THC-CBD vs. existing drugs
At the second stage of this research, 79 patients with severe migraine were included, as well as 48 patients with cluster headache.
The patients with severe migraine were offered THC-CBD (200milligrams daily) or of amitriptyline (25 milligrams) – an antidepressant usually used in migraine treatments.
The cluster headache patients were offered THC-CBD (200 milligrams) every day or verapamil (480 milligrams) – this is a calcium channel blocker usually used for cluster headache treatments.
Patients took extra 200 milligram of THC-CBD when they experienced acute pain.
Both cluster headache and severe migraine patient’s treatments lasted for 3 months, and the patience were observed for another four weeks after the treatment has ended. When compared with amitriptyline – with a decrease of 40.4% and 40.1% accordingly.
Furthermore, THC-CBD reduced the intensity of acute pain among the patients with migraine by 43.5%. It only had effects on individuals who had experienced migraine as a child.
From these results, it was concluded that cannabidiol has similar effects as other available medications for the prevention of migraine; however, these benefits may be restricted for cluster headache patients.
“We have successfully shown that cannabidiol is a substitute treatment for migraine. Having said that, only acute treatments for patients with cluster headaches and have experienced migraine since childhood are appropriate for this treatment.”